Induction of p2l(Waf1/Cip1) by TNFα requires NF-κB activity and antagonizes apoptosis in Ewing tumor cells

Oncogene

Volumn 19, Issue 1, 2000, Pages 61-68

  Javelaud, Delphine ^a   Wietzerbin, Juana ^a   Delattre, Olivier ^a   Besançon, Françoise ^a  

^a INSTITUT CURIE   (France)

Author keywords

Apoptosis; Ewing tumor; NF B; p21(WAF1 Cip1); TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA BINDING PROTEIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

APOPTOSIS; ARTICLE; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; EWING SARCOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; CELL CULTURE; DRUG EFFECT; PATHOLOGY; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; SARCOMA, EWING'S; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034610544     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203246     Document Type: Article

References (57)

1. Arsura M, Wu M and Sonenshein GE. (1996). Immunity, 5, 31-40.
2. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumoro K and Mizutani S. (1999). EMBO J., 18, 1223-1234.
3. Baeuerle PA and Henkel T. (1994). Annu. Rev. Immunol., 12, 141-179.
4. Baeuerle PA and Baltimore D. (1996). Cell, 87, 13-20.
5. Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G and Ghysdael J. (1994). Mol. Cell. Biol., 14, 3230-3241.
6. Baldwin AS, Jr. (1996). Annu. Rev. Immunol., 14, 649-681.
7. Beg AA and Baltimore D. (1996). Science, 274, 782-784.
8. Bertrand F, Atfi A, Cadoret A, L'Allemain G, Robin H, Lascols O, Capeau J and Cherqui G. (1998). J. Biol. Chem., 273, 2931-2938.
9. Besançon F, Atfi A, Gespach C, Cayre YE and Bourgeade MF. (1998). Proc. Nat. Acad. Sci. USA, 95, 8081-8086.
10. Brach MA, Hass R, Sherman ML, Gunji H, Weichselbaum R and Kufe D. (1991). J. Clin. Invest., 88, 691-695.
11. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ. (1995). Nature, 377, 552-557.
12. Cai Z, Kôrner M, Tarantino N and Chouaib S. (1997). J. Biol. Chem., 272, 96-101.
13. Cheng B, Christakos S and Mattson MP. (1994). Neuron, 12, 139-153.
14. Das KC and White CW. (1997). J. Biol. Chem., 272, 14914-14920.
15. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A and Thomas G. (1992). Nature, 359, 162-165.
16. DeLuca C, Kwon HJ, Pelletier N, Wainberg MA and Hiscott J. (1998). Virology, 244, 27-38.
17. Fisher DE. (1994). Cell, 73, 539-542.
18. Gartel AL and Tyner AL. (1999). Exp. Cell Res., 246, 280-289.
19. Gorospe M, Wang X, Guyton KZ and Holbrook NJ. (1996). Mol. Cell. Biol., 16, 6654-6660.
20. Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC and Holbrook NJ. (1997). Oncogene, 14, 929-935.
21. Green DR. (1998). Cell, 94, 695-696.
22. Grilli M, Pizzi M, Memo M and Spano P. (1996). Science, 274, 1383-1385.
23. Grilli M and Memo M. (1999). Cell Death Diff., 6, 22-27.
24. Horowitz ME, Malawer MM, Woo SY and Hicks MJ. (1997). Principles and Practice of Pediatric Oncology. Pizzo PA and Poplack DG. (eds). Lippincott-Raven: Philadelphia, pp. 831-864.
25. Jäättelä M. (1999). Exp. Cell Res., 248, 30-43.
26. Jiang Y and Porter AG. (1998). Biochem. Biophys. Res. Comm., 245, pp. 691-697.
27. Kovar H, Aryee DNT, Jug G, Henöckl C, Schemper M, Delattre O, Thomas G and Gadner H. (1996). Cell Growth Diff., 7, 429-437.
28. Lipinski M, Braham K, Philip I, Wiels J, Philip T, Goridis C, Lenoir GM and Tursz T. (1987). Cancer Res., 47, 183-187.
29. Liu Z, Hsu H, Goeddel DV and Karin M. (1996). Cell, 87, 565-576.
30. Lu Y, Yamagishi N, Yagi T and Takebe H. (1998). Oncogene, 16, 705-712.
31. Maniatis T. (1997). Science, 278, 818-819.
32. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R and Denny CT. (1993a). Mol. Cell. Biol., 13, 7393-7398.
33. May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G and Denny CT. (1993b). Proc. Nat. Acad. Sci. USA, 90, 5752-5756.
34. Melot T, Gruel N, Doubeikovski A, Sevenet N, Teillaud JL and Delattre O. (1997). Hybridoma, 16, 457-464.
35. Munoz E, Courtois G, Veschambre P, Jalinot P and Israel A. (1994). J. Virol., 68, 8035-8044.
36. Noguera R, Triche TJ, Navarro S, Tsokos M and Llombart-Bosch A. (1992). Lab. Invest., 66, 143-151.
37. Ohno T, Rao VN and Reddy ES. (1993). Cancer Res., 53, 5859-5863.
38. O'Regan S, Diebler MF, Meunier FM and Vyas S. (1995). J. Neurochem., 64, 69-76.
39. Ouchida M, Ohno T, Fujimura Y, Rao VN and Reddy ESP. (1995). Oncogene, 11, 1049-1054.
40. Polyak K, Waldman T, He TC, Kinzler KW and Vogelstein B. (1996). Genes Dev., 10, 1945-1952.
41. Shim J, Lee H, Park J, Kim H and Choi EJ. (1996). Nature, 381, 804-807.
42. Sorensen PHB, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ and Denny CT. (1994). Nat. Genet., 6, 146-151.
43. Stancovski I and Baltimore D. (1997). Cell, 91, 299-302.
44. Suzuki A, Tsutomi Y, Akahane K, Araki T and Miura M. (1998). Oncogene, 17, 931-939.
45. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S and Bauerle PA. (1995). EMBO J., 14, 2876-2883.
46. Tanaka K, Iwakuma T, Harimaya K, Sato H and Iwamoto Y. (1997). J. Clin. Invest., 99, 239-247.
47. Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM. (1996). Science, 274, 787-789.
48. Verma IM, Stevenson JK, Schwaetz EM, Van Antwerp D and Miyamoto S. (1995). Genes Dev., 9, 2723-2735.
49. Wang CY, Mayo MW and Baldwin Jr AS. (1996). Science, 274, 784-787.
50. Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin Jr AS. (1998). Science, 281, 1680-1683.
51. Wang CY, Cusack Jr JC, Liu R and Baldwin Jr AS. (1999a). Nature Med., 5, 412-417.
52. Wang Y, Blandino G and Givol D. (1999b). Oncogene, 18, 2643-2649.
53. Wang YA, Elson A and Leder P. (1997). Proc. Nat. Acad. Sci. USA, 94, 14590-14595.
54. Whiteside ST. Epinat J, Rice NR and Israel A. (1997). EMBO J., 16, 1413-1426.
55. Yi H, Fujimura Y, Ouchida M, Prasad DDK, Rao VN and Reddy ESP. (1997). Oncogene, 14, 1259-1268.
56. Zong WX, Edelstein LC, Chen C, Bash J and Gelinas C. (1999). Genes Dev., 13, 382-387.
57. Zucman J, Delattre O, Desmaze C, Epstein A, Stenman G, Speleman F, Fletchers CDM, Aurias A and Thomas G. (1993). Nat. Genet., 4, 341-345.